JZP-MA-13 is a selective α/β-hydrolase domain 6 (ABHD6) inhibitor with an IC 50 of 392 nM. JZP-MA-13 shows no inhibition of MAGL , ABHD12, FAAH , or other serine hydrolases . JZP-MA-13 is a positron emission tomography (PET) ligand for in vivo imaging of the ABHD6.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > MAGL
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.